Dataset Information

The Blending of Poly(glycolic acid) with Polycaprolactone and Poly(l-lactide): Promising Combinations.

ABSTRACT: Poly(glycolic acid) (PGA) holds unique properties, including high gas barrier properties, high tensile strength, high resistance to common organic solvents, high heat distortion temperature, high stiffness, as well as fast biodegradability and compostability. Nevertheless, this polymer has not been exploited at a large scale due to its relatively high production cost. As such, the combination of PGA with other bioplastics on one hand could reduce the material final cost and on the other disclose new properties while maintaining its "green" features. With this in mind, in this work, PGA was combined with two of the most widely applied bioplastics, namely poly(l-lactide) (PLLA) and poycaprolactone (PCL), using the melt blending technique, which is an easily scalable method. FE-SEM measurements demonstrated the formation of PGA domains whose dimensions depended on the polymer matrix and which turned out to decrease by diminishing the PGA content in the mixture. Although there was scarce compatibility between the blend components, interestingly, PGA was found to affect both the thermal properties and the degradation behavior of the polymer matrices. In particular, concerning the latter property, the presence of PGA in the blends turned out to accelerate the hydrolysis process, particularly in the case of the PLLA-based systems.

SUBMITTER: Magazzini L

PROVIDER: S-EPMC8400216 | biostudies-literature |

REPOSITORIES: biostudies-literature

ACCESS DATA

Similar Datasets

Project description:In the current study, we synthesized prostate cancer-targeting poly(lactide-co-glycolic acid) (PLGA) nanobubbles (NBs) modified using A10-3.2 aptamers targeted to prostate-specific membrane antigen (PSMA) and encapsulated paclitaxel (PTX). We also investigated their impact on ultrasound (US) imaging and therapy of prostate cancer. PTX-A10-3.2-PLGA NBs were developed using water-in-oil-in-water (water/oil/water) double emulsion and carbodiimide chemistry approaches. Fluorescence imaging together with flow cytometry verified that the PTX-A10-3.2-PLGA NBs were successfully fabricated and could specifically bond to PSMA-positive LNCaP cells. We speculated that, in vivo, the PTX-A10-3.2-PLGA NBs would travel for a long time, efficiently aim at prostate cancer cells, and sustainably release the loaded PTX due to the improved permeability together with the retention impact and US-triggered drug delivery. The results demonstrated that the combination of PTX-A10-3.2-PLGA NBs with low-frequency US achieved high drug release, a low 50% inhibition concentration, and significant cell apoptosis in vitro. For mouse prostate tumor xenografts, the use of PTX-A10-3.2-PLGA NBs along with low-frequency US achieved the highest tumor inhibition rate, prolonging the survival of tumor-bearing nude mice without obvious systemic toxicity. Moreover, LNCaP xenografts in mice were utilized to observe modifications in the parameters of PTX-A10-3.2-PLGA and PTX-PLGA NBs in the contrast mode and the allocation of fluorescence-labeled PTX-A10-3.2-PLGA and PTX-PLGA NBs in live small animals and laser confocal scanning microscopy fluorescence imaging. These results demonstrated that PTX-A10-3.2-PLGA NBs showed high gray-scale intensity and aggregation ability and showed a notable signal intensity in contrast mode as well as aggregation ability in fluorescence imaging. In conclusion, we successfully developed an A10-3.2 aptamer and loaded PTX-PLGA multifunctional theranostic agent for the purpose of obtaining US images of prostate cancer and providing low-frequency US-triggered therapy of prostate cancer that was likely to constitute a strategy for both prostate cancer imaging and chemotherapy.

Dataset Information

The Blending of Poly(glycolic acid) with Polycaprolactone and Poly(l-lactide): Promising Combinations.

Similar Datasets

OmicsDI is part of the ELIXIR infrastructure

Tweets